[Formation and aggregation behavior of polyethyleneimine-DNA complexes]. 2009

Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

In vitro gene delivery, polyethyleneimine (PEI) has been described as one of the most efficient nonviral vector. Herein the formation mechanism of PEI/DNA complexes is elucidated. The transition phase of "bead-on-string" structure in the formation of complexes was supposed to exist through spectroscopy, electrophoresis and transmission electron microscopy (TEM) technology. The construction of PEI/DNA complexes is related closely to the characteristics of PEI and DNA plasmid. As well as the dominant electrostatic effects, the nonelectrostatic interactions were thought to be partially responsible for the presence of PEI/DNA complexes even in the high ionic strength. The surface charge of complexes particles increased with the N/P ratio, but the absolute value of zeta potential was lower at the N/P ratio of 8 and 12, perhaps attributed to the use of larger DNA plasmid. As a result, the repulsion between particles was decreased and prone to aggregate to the structure like a clustered grape-string in the solution. Interestingly, contrast to the formation behavior of complexes, the PEI/DNA complexes aggregated primarily due to hydrophobic interactions while electrostatic attractions play a little role in the complexes particles aggregation in different concentrations of salt solutions. Comparable transfection efficiency in HepG2 cells was observed for the Lipofectamine 2000 and PEI/DNA complexes at the N/P ratio of 12, and showed that larger or aggregable complexes could transfect the cells in some different mechanisms.

UI MeSH Term Description Entries
D011094 Polyethyleneimine Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e). Polyaziridine,Polyethylenimine,Polyaziridines,Polyethyleneimines,Polyethylenimines
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015316 Genetic Therapy Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions. Gene Therapy,Somatic Gene Therapy,DNA Therapy,Gene Therapy, Somatic,Genetic Therapy, Gametic,Genetic Therapy, Somatic,Therapy, DNA,Therapy, Gene,Therapy, Somatic Gene,Gametic Genetic Therapies,Gametic Genetic Therapy,Genetic Therapies,Genetic Therapies, Gametic,Genetic Therapies, Somatic,Somatic Genetic Therapies,Somatic Genetic Therapy,Therapies, Gametic Genetic,Therapies, Genetic,Therapies, Somatic Genetic,Therapy, Gametic Genetic,Therapy, Genetic,Therapy, Somatic Genetic
D018014 Gene Transfer Techniques The introduction of functional (usually cloned) GENES into cells. A variety of techniques and naturally occurring processes are used for the gene transfer such as cell hybridization, LIPOSOMES or microcell-mediated gene transfer, ELECTROPORATION, chromosome-mediated gene transfer, TRANSFECTION, and GENETIC TRANSDUCTION. Gene transfer may result in genetically transformed cells and individual organisms. Gene Delivery Systems,Gene Transfer Technique,Transgenesis,Delivery System, Gene,Delivery Systems, Gene,Gene Delivery System,Technique, Gene Transfer,Techniques, Gene Transfer,Transfer Technique, Gene,Transfer Techniques, Gene

Related Publications

Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
January 2004, Methods in molecular biology (Clifton, N.J.),
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
February 2000, Molecular therapy : the journal of the American Society of Gene Therapy,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
January 1969, Doklady Akademii nauk SSSR,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
February 2009, Human gene therapy,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
May 2011, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
July 1964, Journal of molecular biology,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
February 2011, Colloids and surfaces. B, Biointerfaces,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
May 2023, Protein science : a publication of the Protein Society,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
August 2003, Molecular therapy : the journal of the American Society of Gene Therapy,
Yun Lu, and Jing Yao, and Jian-Ping Zhou, and Wei Wang, and Zu-Yuan Deng, and Li-Ye Guan
January 2015, Journal of photochemistry and photobiology. B, Biology,
Copied contents to your clipboard!